Search for Clinical Trial Results

Sponsored By

Polymorphic Reticulosis - 2 Studies Found

Status Study
Completed Study Name: Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies
Condition: Recurrent or Refractory T/NK-cell Malignancies
Date: 2009-01-08
Interventions:
  • Drug: forodesine hydrochloride

Active, not recruiting Study Name: CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
Condition:
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
  • Myelod
    Date: 2008-07-03
    Interventions: Biological: Allodepleted T Cells Dose Level 1 = 1 x 10e6 T